Friday, March 8, 2019

New Ketamine treatment for Depression










New ketamine-related drug could be ‘watershed’ in treating depression

‘Rapid acting’ esketamine was approved by the FDA to treat people who don’t respond to traditional psychiatric drugs
Spravato was approved by the US Food and Drug Administration for patients with hard-to-treat depression.
 Spravato was approved by the US Food and Drug Administration for patients with hard-to-treat depression. Photograph: AP
https://www.theguardian.com/society/2019/mar/08/new-ketamine-related-drug-could-be-watershed-in-treating-depression

No comments:

Post a Comment